Comprehensive Study Guide on Pain Pathways, Cannabis Pharmacology, and Tramadol

Pain Transmission and Pharmacological Intervention Pathways

  • Calcium Channel Blockers     * These agents iterate the action potential and the sending of messages along specific pathways.     * They work by altering the message apparently along with the pathways, which then travel up and alter each subject's response.

  • Opioids and Chemical Transmission     * Opioids function by blocking the release of neurotransmitters.     * This chemical interference reduces the transmission of the pain signal along the aberrant pathway.

  • Phases of the Pain Response     * Transduction: This is the beginning of the pain method or response. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) primarily act during this phase.     * Transmission: The movement of the signal along the nerves.     * Perception: This involves the brain's interpretation of pain. Opioids play a major role in perception, specifically regarding the euphoria effect.     * Modulation: This phase enhances the body's own natural pain control systems, strengthening the inhibitory pathways.

  • Synergistic Effects     * Refers to the use of combination drugs where two or more substances combined produce an effect greater than the sum of their individual effects (2+2>42 + 2 > 4).

Cannabis: Compounds and Clinical Significance

  • Legalization and General Indications     * Cannabis is legalized in Canada for medical indications and recreational use.     * It is often used as an adjunctive treatment rather than a primary monotherapy.

  • Primary Active Ingredients     * THC (Tetrahydrocannabinol): The psychoactive component responsible for the "high" or euphoria. It acts on cannabinoid receptors in the brain, influencing pleasure, memory, thought, concentration, sensory perception, time perception, and coordinated movement.     * CBD (Cannabidiol): A non-psychoactive cannabinoid. It possesses therapeutic healing properties without the euphoria. It is used for its anti-epileptic, anti-inflammatory, anti-emetic, muscle-relaxing, and anxiolytic (anxioanalytic) properties.

  • Potency and Risks     * Different strains have varying quantities of THC and CBD. High-potency marijuana (significant in Ontario, where levels are up to 30%30\% higher than previously recorded) carries greater risks.     * Psychosis: There is a significant risk of a "one-time experience" of psychosis leading to a psychotic break, especially in younger persons. Persons as young as 1515 years old show increased risk for schizophrenia (specifically in boys) and bipolar disorder (specifically in women) associated with early use.     * Seizures: Research notes that 94%94\% of seizures may be associated with high-potency marijuana.

Physiological Mechanics and Therapeutic Benefits

  • The Endocannabinoid System (ECBs)     * Endocannabinoids and their receptors are found throughout the body: immune cells, glands, connective tissue, and internal organs.     * They play a homeostatic role governed by the mantra: "Eat, sleep, relax, forget, and protect."         * Eat: Regulates appetite and food-seeking behavior.         * Sleep: Manages sleep cycles and resets the circadian rhythm.         * Relax: Manages stress and anxiety.         * Forget: Involved in neuronal plasticity and helps inhibit old fear-based memories (useful in PTSD).         * Protect: Provides both immune and neuroprotection; regulates the inflammation system.

  • Specific Clinical Indications     * Chronic Pain: Useful for non-cancer pain, Fibromyalgia (fibro), and arthritis.     * Neuropathic Pain: Specifically mentioned for benefit in Multiple Sclerosis (MS).     * Cancer Support: Used as adjunctive treatment for adult cancer patients and those with Immunodeficiency Syndrome (AIDS).     * Secondary Symptoms: Effective for anorexia/weight loss and nausea/vomiting associated with chemotherapy.     * Oncology: THC and CBD are noted to inhibit colon cancer cell proliferation.

Pharmacokinetics and Administration

  • Absorption and Distribution     * THC is mostly absorbed by tissues and organs but has a high affinity for adipose (fat) tissue, where it is stored.

  • Elimination and Half-Life     * Infrequent Use: The half-life for an infrequent user is approximately 1.5 days1.5\,days.     * Frequent Use: The half-life extends to a range of 55 to 13 days13\,days because higher levels stick around and store in fat.     * Detection Windows:         * Urine: Metabolites can be found for up to a week after inhalation or up to 90 days90\,days for full elimination.         * Hair: Can be detected for months after consumption.

  • Methods of Delivery     * Inhalation (Smoking/Vaping): Enters the system quickly, requiring a lower concentration for the euphoric experience. However, smoke is carcinogenic and contains toxins like ammonia and cyanide.     * Oral Consumption (Edibles/Liquid): Subject to first-pass metabolism in the liver. This requires higher levels of the drug to achieve the same effect compared to smoking.

Dependence and Toxicological Considerations

  • Nature of Addiction     * Cannabis is characterized by a psychological or behavioral dependence (addiction to the feeling of relaxation and lack of stress) rather than a physical dependence.     * There is NO physiological withdrawal (unlike alcohol or benzodiazepines).     * Tolerance develops with regular use; routine consumers can manage higher THC concentrations than "naïve" individuals.

  • Comparative Withdrawal Risks     * Alcohol, Benzodiazepines, and Steroids: Abrupt cessation can be life-threatening (e.g., risk of seizures).     * THC: Can be stopped abruptly. Challenges are primarily psychological, though users may experience disrupted sleep or increased memory activity because the drug's aid in the sleep cycle is removed.

Tramadol (Atypical Opioid)

  • Classification and Indication     * Classified as a non-opioid but fits into the opioid class as an "atypical opioid."     * Used for moderate to moderately severe pain.

  • Mechanism of Action     * Has dual action:         1. Binds weakly to opioid receptors.         2. Interferes with norepinephrine reuptake and inhibits serotonin uptake in the brain.

  • Pharmacokinetics and Safety     * Metabolized in the liver; requires assessment of liver function.     * Adverse Effects: Drowsiness, dizziness, headache, nausea, constipation, and respiratory depression.     * Contraindications: Allergy to the drug, consumption of alcohol, use of other CNS depressants, or psychoactive/psychotropic drugs.     * Drug-Drug Interactions: High risk when taken with Tricyclic Antidepressants or SSRIs (Serotonin Selective Reuptake Inhibitors) due to potentially dangerous cumulative effects on neurotransmitter levels.

Questions & Discussion

  • Question: Is CBD available in forms other than oral liquid?

  • Response: Yes, it can be found in various formulations. Prescription versions exist, and health food stores often carry it as a naturalistic healing remedy.

  • Question: Can someone dependent on alcohol just quit immediately?

  • Response: No. Alcohol and benzodiazepines (or steroids) require tapered withdrawal because abrupt cessation risks seizures. THC does not have this physiological withdrawal requirement.

  • Question: What are the adverse effects of quitting THC if there is no physical withdrawal?

  • Response: Users may experience difficulty sleeping because THC helps reset the circadian rhythm. Without it, the body must relearn to manage the sleep cycle independently. There may also be increased mental activity or anxiety.